SPOTLIGHT -
Mike Hollan is an assistant managing editor for Pharmaceutical Executive and Medical Device and Technology and can be reached at mhollan@mjhlifesciences.com.
How Quantum Computing Trends Will Impact Pharma in 2024: Q&A With Erik Huestis, Partner at Foley Hoag
Huestis discusses the ways that quantum simulation and quantum systems can be used in areas such as drug discovery and the creation and protection of intellectual property in the life sciences industry.
The Top 5 Q&As of 2023
Pharm Exec spent the year speaking with some of the most interesting professionals from the life sciences industry.
The Top 5 DE&I Stories in 2023
As companies continued to expand their DE&I efforts, Pharm Exec was there to cover it in 2023.
Top Marketing Stories of 2023
Pharma marketing teams had to deal with big changes in 2023.
Top 5 AI Stories of 2023
As this exciting technology exploded in 2023, Pharm Exec was there to cover it all.
The Cover Stories of 2023
These stories graced the cover of Pharmaceutical Executive this year
The Importance of Data in 2024: Q&A With Christoph Bug, Vice President of Global Medical at Veeva
Data will continue to grow in importance in 2024.
Finding that Spark
Lisa Conte, founder, president, and CEO of Jaguar Health, discusses how a climb up Mount Kilimanjaro would vault her to her true career calling—and spark a decades-long quest to accelerate breakthroughs in plant-based pharmaceuticals and supportive care.
Clearing Away the Clutter: Implementing Value-Based Contracting in Pharma
Experts gauge whether the needle is finally moving on the effective structuring of outcomes centered payment agreements—from operational, technology, and acceptance standpoints.
It’s Always Important to Remember: Leaders Make Mistakes
Continuous learning a vital skill for aspiring and established leaders alike.
Market Trends To Watch in 2024: Q&A With Seth Farbman, Chairman and Co-Founder of VStock Transfer
Farbman discusses the struggles that pharma companies are facing when trying to raise funds and how this is impacting IPOs.
Mapping the Reproductive Patient Journey: Q&A With David Powley, VP of Reproductive Medicine and Maternal Health and Operations at Ferring Pharmaceuticals
Powley discusses his team’s recent patient journey mapping exercise and the impact it has had on RMMH.
Reacting to Trends: Q&A With Leslie Orne, CEO of Trinity Life Sciences
Orne discusses the forces impacting the life sciences market and how companies are reacting.
Building a Better Toolbox For Patient Enrollment: Q&A With Kimberlee Heidmann, Co-Founder of Scout Clinical
Heidmann discusses the difficulties of enrolling patients in clinical trials and the ways these issues can be dealt with.
Piloting New Drug Development: Q&A With Dr. Bruce Leuchter, Ceo of Neurvati
Leuchter discusses FDA’s new pilot program.
Getting Proactive About Signal Detection: Q&A With Elizabeth Smalley, Director of Product Management, Data, and Analytics at ArisGlobal
Smalley discusses her work with proactive signal detection.
New Ways to Battle Cancer: Q&A With William Ho, CEO of IN8bio
Ho discusses how gamma-delta T cells can improve cancer treatments.
Q&A With Jade Shields, Vice President of Corporate Affairs at Ferring Pharmaceuticals
Shields discusses Ferring’s recent $5 million endowment to the American Society of Reproductive Medicine.
Fighting Autoimmune Diseases and Developing Leadership Skills Along the Way: Q&A With Dr. Mike McCullar, CEO of RegCell
McCullar discusses his new role as CEO of RegCell.
Pharma Should Embrace the Single Sign-On
There is no cure for having to remember countless logins/passwords.
Fighting Against Antimicrobial Resistance With Phage: Q&A With Jonathan Solomon, CEO of BiomX
Solomon discusses new ways that researchers are fighting against bacterial resistance to medications.
Battling the Cancer Drug Shortage: Q&A With Anshul Mangal, President of Project Farma and Precision Advance
Mangal discusses the causes of the shortage and how pharma companies can find solutions.
Q&A With Ramees Raja, Global Energy Manager at Almac Group
Raja discusses how the pharma industry can improve its ecological impact.
Q&A With Joe Schmidt, EVP, Head of Customer Services and Success at Medidata
Schmidt discusses the recent announcement that Medidata and the NCI extended their partnership an additional five years.
Q&A With Derron Stark, Managing Director of Strategy and Transactions at EY
Stark discusses pharma’s supply chain and the issues it is facing.
Generating Pharma’s AI: Q&A With Masanori Ito, Senior Director, Head of Enterprise Insights and Digital Solutions, Digital, Analytics, and Technology at Astellas
Ito discusses how data-driven AI can be utilized by the pharma industry.
Raising Funds in a Tight Market: Q&A With Sharon Cunningham, CEO of Shorla Oncology
Cunningham discusses the obstacles to raising funds in the current climate.
2023 Pharmaceutical Executive APEX Award Winners
Q&A With Dr. Ronald A. Morton, Chief Medical Officer, Urology, Boston Scientific
Morton discusses his transition from working as a urologist to the C-suite.
Centered on Decentralized Trials: Q&A With Harpreet Gill, Head of Decentralized Clinical Trials at Icon
Gill discusses her continuing work to transform clinical trials and improve the patient experience through DCTs.